MICA產(chǎn)品信息
物種:Human / Cynomolgus
屬性:Protein
標(biāo)記:Biotin-labeled / Unconjugated
分子別名(Synonym)
MIC-A
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
MICA分子背景
MHC I類多肽相關(guān)序列A(MICA)屬于MHC I類家族和MIC亞家族。MICA包含一個Ig樣C1型(免疫球蛋白樣)結(jié)構(gòu)域。與經(jīng)典的MHC I類分子不同,MICA不會與β-2-微球蛋白形成異二聚體。MICA作為一種應(yīng)激誘導(dǎo)的自身抗原,被γδT細胞識別。MICA是KLRK1/NKG2D受體的配體。MICA與KLRK1結(jié)合導(dǎo)致細胞裂解。
MICA用戶評價
關(guān)鍵字: MICA;MICA蛋白;MIC-A;MICA重組蛋白;MIC-A蛋白;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。